Scientists at Israel's Krassett have developed a device that can help with myocardial relaxation. Patients with diastolic disorders use the device to promote blood circulation and reduce the risk of heart attack.
This development by Krassett is a self-expanding device that can be placed on the outer surface of the left heart. When the heart muscle contracts, the device absorbs the accumulated energy and releases it to the left ventricle during the diastolic phase. Maintain muscle elasticity, improve myocardial function and blood circulation.
At present, they have conducted clinical trials on 3 people, indicating that the device is safe to implant into the heart and has the effect of improving myocardial function.
Heart muscles may become dysfunctional during blood circulation due to heart attack or heart disease due to obesity and congenital genetic defects. There are two main situations, one is contractile dysfunction, which occurs during the contraction phase in which the heart squeezes blood to the whole body; the other is diastolic dysfunction, which occurs when the blood returns to the diastolic phase of the heart, at which time the heart muscle is inappropriate. Relax and make it difficult for the body to return to the heart. According to statistics, 30% to 55% of the world's 25 million heart disease patients are diastolic dysfunction.
The company's total Amir Loshakov said that at present, some devices have been developed to treat systolic dysfunction, but there is no effective treatment for diastolic dysfunction. The device they developed provides a new way to treat diastolic dysfunction. He said that next year they are preparing for a larger trial and hope to be released to the US market within two years after obtaining approval from the US Food and Drug Administration.
This development by Krassett is a self-expanding device that can be placed on the outer surface of the left heart. When the heart muscle contracts, the device absorbs the accumulated energy and releases it to the left ventricle during the diastolic phase. Maintain muscle elasticity, improve myocardial function and blood circulation.
At present, they have conducted clinical trials on 3 people, indicating that the device is safe to implant into the heart and has the effect of improving myocardial function.
Heart muscles may become dysfunctional during blood circulation due to heart attack or heart disease due to obesity and congenital genetic defects. There are two main situations, one is contractile dysfunction, which occurs during the contraction phase in which the heart squeezes blood to the whole body; the other is diastolic dysfunction, which occurs when the blood returns to the diastolic phase of the heart, at which time the heart muscle is inappropriate. Relax and make it difficult for the body to return to the heart. According to statistics, 30% to 55% of the world's 25 million heart disease patients are diastolic dysfunction.
The company's total Amir Loshakov said that at present, some devices have been developed to treat systolic dysfunction, but there is no effective treatment for diastolic dysfunction. The device they developed provides a new way to treat diastolic dysfunction. He said that next year they are preparing for a larger trial and hope to be released to the US market within two years after obtaining approval from the US Food and Drug Administration.
Organic Red Wolfberry,Dried Red Wolfberry,Goji Berry Ningxia Wolfberry,Red Color Dried Goji Berry
NINGXIA STARLIGHT FOOD TRADE CO.,LTD , https://www.starlightfood.com